News and Perspective
Metastatic Breast Cancer
- Treating Metastatic TNBC: Where Are We Now?
- ENDO 2021 Denosumab Now Dominant Therapy for Cancer-Associated Osteoporosis
- Vitamin D for All Over 50s to Prevent Cancer Deaths?
- Treatment of Metastatic Triple-Negative Breast Cancer: Sacituzumab Govitecan
- A Patient Insisted on a Trial. Docs Listened and Saved Lives
- How Has COVID-19 Affected MBC Treatment Decisions?
- Obesity 'Clearly' Not Tied to Worse Survival in MBC
- Finally, ALS Patients Gain Faster Access to Disability Payments
- Entinostat Doesn't Overcome Endocrine Resistance in Breast Cancer
- Margetuximab for HER2+ Metastatic Breast Cancer Falls Short
- CONTESSA: Oral Taxane Meets Primary Endpoint
- Social Media for Cancer Trial Recruitment? 'Not at This Time.'
- Advances in HER2+ MBC From SABCS 2020
- Highlights in Metastatic Breast Cancer From SABCS 2020
- Alert Margetuximab Approved for HER2+ Metastatic Breast Cancer
- SABCS 2020 A Disappointment in Triple-Negative Breast Cancer
- Alert EMA Panel Endorses Approval of Five New Cancer Drugs
- SABCS 2020 CTCs Predict Overall Survival in Metastatic Breast Cancer
- SABCS 2020 SABCS 2020: What's Hot, Including a Major Chemotherapy Trial
- Should CTCs Guide Treatment Choice in HR+, HER2– Breast Cancer?